Using low level laser therapy to treat fecal incontinence

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of low level laser therapy (LLLT) for patients suffering from severe refractory fecal incontinence. Participants will undergo a 3-week treatment regimen consisting of 8 sessions of LLLT. The study will assess the therapy's impact on symptoms and quality of life through questionnaires and physiological evaluations of pelvic floor function at 4 and 12 weeks post-treatment. This proof of concept study does not include a placebo group.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients with fecal incontinence

Exclusion Criteria:

* Pregnant patients
* Known malignancies in the area of treatment
* Active bleeding in area of treatment
* Active deep vein thrombosis
* When tatoos are present at area of treatment
* Patients that are light sensitive
* Patients who take steroids.

Where it's running

• McMaster University
  Hamilton, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Jihong Chen, MD PhD — McMaster University
• Study coordinator: Jihong Chen, MD PhD
• Email: chen338@mcmaster.ca
• Phone: 1-226-3439909

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Active vs. Passive Anal Sphincter Training in Fecal Incontinence

  This home-based trial tests whether adding active sphincter contractions to electrical stimulation helps adults with fecal incontinence more than stimulation alone.

  Recruiting University Hospital, Martin · Martin · NCT07604415

• Beta-glucan cream added to standard skin care for IAD in hospitalized adults

  This study tests whether adding a 0.5% beta-glucan moisturizing cream to usual skin care helps adults with incontinence-associated dermatitis heal faster and feel better.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07524439

• R20 Sacral Neuromodulation for Fecal Incontinence: Post‑Market Follow‑Up

  This registry test checks how well the Axonics R20 rechargeable device works for adults with fecal incontinence after it’s on the market.

  Recruiting at 4 sites Axonics, Inc. · New York, New York and 4 other locations · NCT07499258

• High-intensity electromagnetic stimulation for bowel control after J-pouch surgery

  Aims to see if the Emsella chair can help people with a J pouch who have fecal incontinence after ulcerative colitis surgery.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT07034443

• Intra-rectal Botulinum Toxin Injection for Children with Non-Retentive Fecal Incontinence

  This trial tests whether injecting botulinum toxin into the rectum can help children who have frequent non-retentive fecal incontinence that isn’t caused by constipation.

  Recruiting Early Phase 1 Shaare Zedek Medical Center · Jerusalem · NCT06785844

• Investigating the effects of sacral neuromodulation on fecal incontinence and the external anal sphincter

  This study is trying to see how a treatment called sacral neuromodulation can help people with fecal incontinence by looking at changes in the muscles around the anus.

  Recruiting Umeå University · Umeå, Västerbotten County · NCT06763861

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.